These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 33326608

  • 21. Characterizing opioid use in a Dutch cohort with migraine.
    van Welie RF, van Welie FC, de Vries Lentsch S, Dahan A, van Velzen M, Terwindt GM.
    Cephalalgia; 2023 May; 43(5):3331024231174160. PubMed ID: 37165775
    [Abstract] [Full Text] [Related]

  • 22. Predictors of treatment-response to acute prescription medications in migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Ezzati A, Buse DC, Fanning KM, Reed ML, Martin VT, Lipton RB.
    Clin Neurol Neurosurg; 2022 Dec; 223():107511. PubMed ID: 36395587
    [Abstract] [Full Text] [Related]

  • 23. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
    Sohn M, Talbert JC, Huang Z, Oser C, Freeman PR.
    Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
    [Abstract] [Full Text] [Related]

  • 24. A population-based survey of Americans with frequent migraine and acute medication use: A plain language summary.
    Starling AJ, Cady R, Buse DC, Buzby M, Lenaburg K.
    Pain Manag; 2024 Mar; 14(7):335-345. PubMed ID: 39292115
    [Abstract] [Full Text] [Related]

  • 25. Identifying the factors underlying discontinuation of triptans.
    Wells RE, Markowitz SY, Baron EP, Hentz JG, Kalidas K, Mathew PG, Halker R, Dodick DW, Schwedt TJ.
    Headache; 2014 Feb; 54(2):278-89. PubMed ID: 24001117
    [Abstract] [Full Text] [Related]

  • 26. Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Lipton RB, Serrano D, Nicholson RA, Buse DC, Runken MC, Reed ML.
    Headache; 2013 Feb; 53(10):1548-63. PubMed ID: 23992516
    [Abstract] [Full Text] [Related]

  • 27. Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse.
    Starling AJ, Cady R, Buse DC, Buzby M, Spinale C, Steinberg K, Lenaburg K, Kymes S.
    J Headache Pain; 2024 Feb 26; 25(1):26. PubMed ID: 38408888
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Real-world opioid use among patients with migraine enrolled in US commercial insurance and risk factors associated with migraine progression.
    Shao Q, Rascati KL, Lawson KA, Barner JC, Sonawane KB, Rousseau JF.
    J Manag Care Spec Pharm; 2022 Nov 26; 28(11):1272-1281. PubMed ID: 36282930
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results from the American Migraine Prevalence and Prevention Study.
    Lipton RB, Munjal S, Buse DC, Bennett A, Fanning KM, Burstein R, Reed ML.
    Headache; 2017 Jul 26; 57(7):1026-1040. PubMed ID: 28603893
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.